Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Clinical Pharmacokinetics|May 28, 2019
Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve OutcomeRick Admiraal, Cornelia M Jol-van der Zijde, Juliana M Furtado Silva, et al.
Journal of Clinical Immunology|August 15, 2023
A Novel CDC42 Variant with Impaired Thymopoiesis, IL-7R Signaling, PAK1 Binding, and TCR Repertoire DiversityKristian Assing, Sofie E Jørgensen, Katrine S Sandgaard, et al.
Journal of Clinical Immunology|April 21, 2020
Urogenital Abnormalities in Adenosine Deaminase DeficiencyRoberta Pajno, Lucia Pacillo, Salvatore Recupero, et al.
The Journal of Allergy and Clinical Immunology|May 6, 2014
Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiencyAmel Hassan, Pamela Lee, Paraskevi Maggina, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 15, 2006
Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioningH Bobby Gaspar, Emma Bjorkegren, Kate Parsley, et al.
Lancet (London, England)|September 5, 2009
Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 studyKarin C Straathof, Kanchan Rao, Matthias Eyrich, et al.
Blood|January 9, 2024
Noncoding mutations drive persistence of a founder preleukemic clone which initiates late relapse in T-ALLDavid O'Connor, Jose Espejo Valle-Inclán, Lucia Conde, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2019
New graft manipulation strategies improve the outcome of mismatched stem cell transplantation in children with primary immunodeficienciesReem Elfeky, Ravi M Shah, Mohamed N M Unni, et al.
Pageof 8